Drug major Cipla today slashed prices of its three generic cancer drugs — Erlocip, Docetax and Capegard — by up to 64%.

The drugs are used for treating lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers, it added.

The lung cancer drug Erlocip will now cost 9,900 rupees for thirty tablets against its earlier price of Rs27,000, while Docetax used for treating breast cancer, head & neck cancer, gastric cancer and bladder cancer will now cost Rs1,650 from its earlier price of Rs3,300, Cipla said in a statement.

Capegard, another cancer drug that treats breast, colon and colorectal cancer will now be available at Rs600 for 10 tablets from its earlier price of Rs1,200, it added.